Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$209.01 - $232.56 $23,409 - $26,046
112 Added 1.3%
8,755 $1.91 Million
Q4 2023

Feb 13, 2024

SELL
$197.69 - $227.29 $118,218 - $135,919
-598 Reduced 6.47%
8,643 $1.96 Million
Q3 2023

Nov 13, 2023

BUY
$201.05 - $221.7 $122,037 - $134,571
607 Added 7.03%
9,241 $1.86 Million
Q2 2023

Aug 11, 2023

BUY
$211.93 - $241.33 $148,986 - $169,654
703 Added 8.86%
8,634 $2.08 Million
Q1 2023

May 11, 2023

BUY
$213.32 - $257.83 $56,316 - $68,067
264 Added 3.44%
7,931 $1.82 Million
Q4 2022

Feb 13, 2023

BUY
$203.72 - $248.97 $578,361 - $706,825
2,839 Added 58.8%
7,667 $1.8 Million
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $528,204 - $676,188
2,579 Added 114.67%
4,828 $989,000
Q2 2022

Aug 12, 2022

SELL
$213.86 - $277.87 $127,674 - $165,888
-597 Reduced 20.98%
2,249 $527,000
Q1 2022

May 13, 2022

SELL
$259.82 - $298.18 $95,873 - $110,028
-369 Reduced 11.48%
2,846 $750,000
Q4 2021

Feb 10, 2022

BUY
$271.6 - $314.21 $35,851 - $41,475
132 Added 4.28%
3,215 $1.01 Million
Q3 2021

Nov 10, 2021

BUY
$274.82 - $308.34 $291,858 - $327,457
1,062 Added 52.55%
3,083 $868,000
Q2 2021

Aug 10, 2021

BUY
$251.87 - $278.14 $45,084 - $49,787
179 Added 9.72%
2,021 $557,000
Q1 2021

May 10, 2021

BUY
$204.88 - $255.03 $48,351 - $60,187
236 Added 14.69%
1,842 $470,000
Q4 2020

Feb 10, 2021

SELL
$186.91 - $214.42 $28,410 - $32,591
-152 Reduced 8.65%
1,606 $327,000
Q3 2020

Nov 13, 2020

SELL
$167.03 - $201.3 $71,488 - $86,156
-428 Reduced 19.58%
1,758 $331,000
Q2 2020

Aug 07, 2020

BUY
$113.31 - $182.44 $247,695 - $398,813
2,186 New
2,186 $363,000
Q1 2020

May 15, 2020

SELL
$104.32 - $195.28 $273,631 - $512,219
-2,623 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$163.48 - $173.61 $428,808 - $455,379
2,623 New
2,623 $444,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.